Motley Fool News Releases and Press Releases From 07/10/24

2024-07-10 08:00:00 ET 2024 has generally been a great time to own tech stocks. For example, owning well-established companies like Nvidia , Amazon , and Alphabet would have given investors 30% to 150% returns in just the first half of the year. These companies share some co...

2024-07-10 07:45:00 ET Nvidia (NASDAQ: NVDA) is one of the most closely watched companies in the world. It was once primarily known as a top supplier of gaming GPUs for PCs, but it subsequently evolved into the dominant producer of high-end data center GPUs. Nvidia now generates...

2024-07-10 07:30:00 ET The trend is not the friend for Baidu (NASDAQ: BIDU) shareholders. China's iconic search engine finds its stock trading 20% lower in the otherwise buoyant 2024, off a blistering 33% over the past year. Many Chinese investments have fallen out of favor lately, ...

2024-07-10 07:30:00 ET Palantir Technologies (NYSE: PLTR) has had a strong 2024, with the stock up more than 60% so far. That means it's more than halfway to a double, so the question becomes, could Palantir double over the entirety of 2024? While Palantir's business is strong, ...

2024-07-10 07:15:00 ET Amazon (NASDAQ: AMZN) is one of the latest additions to the $2 trillion valuation club. This exclusive group comprises only five companies, but these also happen to be some of the most dominant businesses on the globe. While many in this group have strong ...

2024-07-10 07:13:00 ET The market has soared since the beginning of 2023. The S&P 500 index has posted a total return level of 48% over that time frame, pushing the index's price-to-earnings ( P/E ) ratio of nearly 29. This is much higher than the long-term market average, w...

2024-07-10 06:53:00 ET Quantum computing expert IonQ (NYSE: IONQ) is going through a tricky growth spurt. First-quarter revenues rose by 77% year over year, but the company is burning lots of cash. Meanwhile, investors have turned away from the previously red-hot quantum computing i...

2024-07-10 06:41:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies ha...

2024-07-10 06:41:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) are a pair of biotechs planning to follow in the footsteps of Novo Nordisk and Eli Lilly and develop GLP-1-targeted medicines for obesity like Wegovy and Zepbound. Both companies ha...

2024-07-10 06:23:00 ET Buying a stock on weakness can be a dangerous idea. Imagine a stock that you think may be a decent buy falls to a new 52-week low. Then a few weeks later, it hits a new low. Then another. And after a while of this tailspin, it's at a multiyear low. That's what m...